Clinical Trials Directory

Trials / Sponsors / Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibr
Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection
Phase 22023-01-10
CompletedStudy Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacterem
Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia
Phase 1 / Phase 22022-04-26
CompletedPh 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aerugi
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas
Phase 1 / Phase 22020-12-22
CompletedA Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent
Dental Caries
Phase 22017-07-07
CompletedA Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
Dental Caries
Phase 22017-02-09
CompletedA Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subj
Dental Caries
Phase 22017-01-27
CompletedAscending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults
Healthy Volunteers
Phase 12016-05-01
CompletedPhase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Sub
Dental Caries
Phase 22015-11-01
CompletedStudy to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Dental Caries
Phase 22015-07-01
CompletedPhase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
Dental Caries
Phase 22014-10-01
CompletedPhase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults
Dental Caries
Phase 22014-02-01
No Longer AvailableIndividual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Th
——
No Longer AvailableIndividual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage T
——